Edoxaban

Definition

An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.

NCIT:C96539 · NCI Thesaurus OBO Edition · CC BY 4.0

Also known as DU-176, EDOXABAN, Ethanediamide, n1-(5-chloro-2-pyridinyl)-n2-((1s,2r,4s)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-, N-(5-chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide — per NCIT

Also identified as

ATC B01AF03 per RXNORM
NCIT NCIT:C96539 per NCIT
SCTID 712778008 per RXNORM
SCTID 714687009 per RXNORM
UNII NDU3J18APO per RXNORM

Indications

Disease	Relation	Source
Stroke	may prevent	MEDRT · Public domain (U.S. Government work)
Pulmonary embolism	may treat	MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ	Side effect / interaction	Source
Cardiovascular system	may treat a disease of this organ	DERIVED · CC BY 4.0

1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.